- 치과 임상에서 보툴리눔 독소의 적용
-
Young Gun Kim, Ji Hee Song, Seong Taek Kim
-
Korean J Headache. 2011;12(1):31-37. Published online June 30, 2011
-
-
-
 Abstract
 PDF
- Botulinum toxin type A(BTX-A), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been applied successfully to treat facial spastic conditions such as blepharospasm, strabismus and cervical dystonia. Since the first reported application in dentistry in 1994, BTX-A has been used with great success to use in the orofacial region to help treat masticatory and facial muscle spasm, hypertrophy of the masticatory muscles, severe bruxism, temporomandibular pain and orofacial neuropathic pain. This review addresses the application of BTX-A in clinical dentistry that expands the indication recently.
- 측두하악장애와 두통의 연관성
-
Young Joo Shim, Seong Taek Kim
-
Korean J Headache. 2009;10(1):79-83. Published online June 30, 2009
-
-
-
Abstract
PDF
- Temporomandibular disorders (TMD) is a collective term embracing a number of clinical problems that involving the masticatory musculature, the TMJ and associated structures, or both. Both headache and TMD are highly prevalent in the general population. These conditions can be disabling and might represent a real contemporary health problem. Although the published estimates of the prevalence of headache and TMD vary widely, some authors have proposed that headache and TMD may related. Among the TMD, myofascial pain has been reported the most common disorder that related to headache. In the previous studies, the central sensitization following continuous nociceptive input of myofascial pain may play a important role in the pathogenesis of migraine and the mechanisms probably involves activation of N-Methyl-DAspartate (NMDA) receptors and production of Nitric Oxide (NO). Therefore the therapy for myofascial pain enhancing central inhibition through pharmacological management or behavioral interventions and simultaneously reducing peripheral inputs through physical therapies, orthopedic appliances and trigger point injections, can be considered as an effective treatment.
- 치과질환과 관련된 두통
-
Seong Taek Kim, Youn Joong Kim , Chong-Youl Kim
-
Korean J Headache. 2003;4(2):96-100. Published online December 31, 2003
-
-
-
Abstract
PDF
- Cranium is complex in neuroanatomical structure and develops variety of disorders exerting a myriads of symptoms and signs. In case of headache, its association with cranial structures such as eyes, nose, ears, teeth, and jaw shows peculiar pain symptoms different to usual feature of pain. Such headaches in dentistry area includes dental, musculoskeletal, neuropathic and neurovascular pain. The author described such headaches likely to be attributable to dental diseases, especially in the context of recently revised international classification of headache disorders of international headache society. Further investigation of well-organized study design is required as there is still debate on whether dental diseases cause head- ache directly. Korean Journal of Headache 4(2):96-100, 2003
- 측두하악장애와 편두통
-
Seong Taek Kim, Youn Joong Kim, Chong-Youl Kim
-
Korean J Headache. 2003;4(1):62-69. Published online June 30, 2003
-
-
-
Abstract
PDF
- Temporomandibular disorders is a collective term embracing a number of clinical problems that in- volve the temporomandibular joint(TMJ), the masticatory muscles, and associated structures. Myofascial pain, one of the most common diagnosis in the TMD classification, is characterized by a regional, dull, aching muscle pain and the presence of localized trigger points in muscle, tendon, or fascia and it has been known as a pathogenetic factor in tension-type headache and migraine. According to the previous studies, the central sensitization following continuous nociceptive input of myofascial pain may play a important role in the pathogenesis of migraine and the mechanisms probably involves activation of N-Methyl-D-Aspartate(NMDA) receptors and production of Nitric Oxide(NO). Therefore the therapy for myofascial pain enhancing central inhibition through pharmacological mana- gement or behavioral interventions and simultaneously reducing peripheral inputs through physical therapies, orthopedic appliances and trigger point injections, can be considered as an effective treatment in migraine patients with myofascial pain. Korean Journal of Headache 4(1):62-69, 2003
|
KHS
